HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan P Dutz Selected Research

2-amino-4-phenylbutyric acid

4/2012Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan P Dutz Research Topics

Disease

11Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022 - 02/2007
6Neoplasms (Cancer)
05/2022 - 04/2004
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 01/2003
5Skin Diseases (Skin Disease)
09/2020 - 07/2007
5Autoimmune Diseases (Autoimmune Disease)
08/2014 - 01/2003
3Psoriatic Arthritis
03/2022 - 02/2007
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 08/2014
3Hypereosinophilic Syndrome (Loeffler Endocarditis)
01/2020 - 04/2017
3Hypersensitivity (Allergy)
11/2019 - 08/2011
3Stevens-Johnson Syndrome (Lyell's Syndrome)
11/2019 - 11/2014
3Melanoma (Melanoma, Malignant)
11/2019 - 03/2007
3Dermatitis
08/2019 - 02/2007
3Cutaneous Lupus Erythematosus
08/2014 - 10/2007
3Inflammation (Inflammations)
08/2014 - 02/2009
2Infections
05/2022 - 09/2020
2Drug Hypersensitivity Syndrome
11/2019 - 11/2016
2Livedoid Vasculopathy
11/2014 - 12/2013
2Cicatrix (Scar)
11/2014 - 12/2013
2Contact Dermatitis (Eczema, Contact)
05/2009 - 02/2006
1Bacterial Vaginosis
01/2022
1Hallucinations (Hallucination)
01/2022
1Myalgia
01/2021
1Fever (Fevers)
01/2021
1VEXAS syndrome
01/2021
1Erythema Nodosum
01/2021
1Arthralgia (Joint Pain)
01/2021
1Virus Diseases (Viral Diseases)
09/2020
1COVID-19
09/2020
1Neutropenia
07/2020
1Gout
11/2019
1Nephritis
08/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Rare Diseases (Rare Disease)
04/2017
1Lymphadenopathy
04/2017
1Eosinophilia
04/2017
1Immunoglobulin G4-Related Disease
04/2017
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2017
1Erythema elevatum diutinum
01/2017
1Drug Hypersensitivity (Drug Allergy)
11/2016
1Ulcer
11/2014
1Polyarteritis Nodosa (Periarteritis Nodosa)
08/2014
1Urticaria (Hives)
08/2014
1Disease Progression
06/2014
1Skin Ulcer
12/2013
1Venous Insufficiency
12/2013
1Colitis
12/2012

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
05/2022 - 11/2016
5Interleukin-12 (IL 12)IBA
03/2022 - 08/2007
4CytokinesIBA
09/2020 - 08/2007
3Interleukin-23 (Interleukin 23)IBA
03/2022 - 09/2014
3Interleukin-17 (Interleukin 17)IBA
03/2022 - 09/2020
3Ustekinumab (CNTO 1275)FDA Link
01/2022 - 09/2014
3AutoantibodiesIBA
08/2019 - 10/2007
3Insulin (Novolin)FDA Link
09/2014 - 01/2003
3InterferonsIBA
06/2012 - 02/2007
3Proteins (Proteins, Gene)FDA Link
06/2012 - 02/2006
3AntigensIBA
08/2011 - 05/2004
2Biological ProductsIBA
02/2022 - 09/2020
2Adalimumab (Humira)FDA Link
02/2022 - 02/2007
2Monoclonal AntibodiesIBA
01/2022 - 09/2014
2Immunoglobulin E (IgE)IBA
09/2020 - 04/2017
2Interferon-alpha (Interferon Alfa)IBA
01/2020 - 03/2007
2CPG-oligonucleotideIBA
11/2019 - 09/2008
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2016 - 11/2014
2Dental Porcelain (Porcelain)IBA
11/2014 - 12/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007 - 02/2007
2Biomarkers (Surrogate Marker)IBA
03/2007 - 02/2007
2Peptides (Polypeptides)IBA
05/2004 - 01/2003
1VaccinesIBA
05/2022
1tofacitinibIBA
03/2022
1ixekizumabIBA
02/2022
1Antirheumatic Agents (DMARD)IBA
02/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Interferon Type IIBA
01/2022
1Antinuclear AntibodiesIBA
01/2022
1EnzymesIBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2020
1HLA-B Antigens (HLA-B)IBA
11/2019
1Allopurinol (Remid)FDA LinkGeneric
11/2019
1Uric Acid (Urate)IBA
11/2019
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
08/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019
1RetinoidsIBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
04/2017
1SteroidsIBA
04/2017
1Rituximab (Mabthera)FDA Link
04/2017
1Immunoglobulin G (IgG)IBA
04/2017
1Lenalidomide (CC 5013)FDA Link
01/2017
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2016
1NexusIBA
02/2016
1Prostaglandins AIBA
01/2015
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2014
1fibrin fragment D (D-dimer)IBA
08/2014
1Messenger RNA (mRNA)IBA
06/2014
1Blood Coagulation Factors (Coagulation Factor)IBA
12/2013
1Vitamin DFDA LinkGeneric
12/2012
11,25-dihydroxyvitamin DIBA
12/2012

Therapy/Procedure

10Therapeutics
05/2022 - 02/2007
3Immunotherapy
09/2020 - 05/2004
1Biological Therapy
01/2019